Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: Central nervous system effects

Cytokine

Volumn 24, Issue 6, 2003, Pages 254-265

  O'Connor, Kevin A ^a   Hansen, Michael K ^a   Pugh, C Rachal ^a   Deak, Molly M ^a   Biedenkapp, Joseph C ^a   Milligan, Erin D ^a   Johnson, John D ^a   Wang, Haichao ^b   Maier, Steven F ^a   Tracey, Kevin J ^b   Watkins, Linda R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

CNS; Cytokine; Endogenous pyrogen; LPS; Mechanical allodynia

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ESCHERICHIA COLI ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; MESSENGER RNA; TUMOR NECROSIS FACTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CALIBRATION; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; FEVER; HYPOTHALAMUS; MALE; MECHANICAL STIMULATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 10744220264     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.08.001     Document Type: Article

References (76)

1. Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci. 26:(3):2001;152-153.
2. Landsman D., Bustin M. A signature for the HMG-1 box DNA-binding proteins. Bioessays. 15:(8):1993;539-546.
3. Stros M. DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences. J Biol Chem. 273:(17):1998;10355-10361.
4. Einck L., Bustin M. The intracellular distribution and function of the high mobility group chromosomal proteins. Exp Cell Res. 156:(2):1985;295-310.
5. Aizawa S., Nishino H., Saito K., Kimura K., Shirakawa H., Yoshida M. Stimulation of transcription in cultured cells by high mobility group protein 1: essential role of the acidic carboxyl-terminal region. Biochemistry. 33:(49):1994;14690-14695.
6. Ge H., Roeder R.G. The high mobility group protein HMG1 can reversibly inhibit class II gene transcription by interaction with the TATA-binding protein. J Biol Chem. 269:(25):1994;17136-17140.
7. Zappavigna V., Falciola L., Helmer-Citterich M., Mavilio F., Bianchi M.E. HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation. Embo J. 15:(18):1996;4981-4991.
8. Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M.E., et al. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol. 18:(8):1998;4471-4487.
9. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:(6149):1987;662-664.
10. Alexander H.R., Doherty G.M., Venzon D.J., Merino M.J., Fraker D.L., Norton J.A. Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats. Surgery. 112:(2):1992;188-193. discussion p. 193-4.
11. Libert C., Vink A., Coulie P., Brouckaert P., Everaerdt B., Van Snick J., et al. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Eur J Immunol. 22:(10):1992;2625-2630.
12. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:(5425):1999;248-251.
13. Sass G., Heinlein S., Agli A., Bang R., Schumann J., Tiegs G. Cytokine expression in three mouse models of experimental hepatitis. Cytokine. 19:(3):2002;115-120.
14. Tracey K.J., Lowry S.F., Fahey T.J. 3rd, Albert J.D., Fong Y., Hesee D., et al. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet. 164:(5):1987;415-422.
15. Butler L.D., Layman N.K., Cain R.L., Riedl P.E., Mohler K.M., Bobbitt J.L., et al. Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention. Clin Immunol Immunopathol. 53:(3):1989;400-421.
16. Fang W.H., Yao Y.M., Shi Z.G., Yu Y., Wu Y., Lu L.R., et al. The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury. Shock. 17:(4):2002;329-333.
17. Wang H., Vishnubhakat J.M., Bloom O., Zhang M., Ombrellino M., Sama A., et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery. 126:(2):1999;389-392.
18. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 192:(4):2000;565-570.
19. Yang H., Wang H., Tracey K.J. HMG-1 rediscovered as a cytokine. Shock. 15:(4):2001;247-253.
20. Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J Immunol. 165:(6):2000;2950-2954.
21. Wagner R., Myers R.R. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport. 7:(18):1996;2897-2901.
22. Eliav E., Herzberg U., Ruda M.A., Bennett G.J. Neuropathic pain from an experimental neuritis of the rat sciatic nerve. Pain. 83:(2):1999;169-182.
23. Chacur M., Milligan E.D., Gazda L.S., Armstrong C., Wang H., Tracey K.J., et al. A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain. 94:(3):2001;231-244.
24. Dinarello C.A. Interleukin-1. Rev Infect Dis. 6:(1):1984;51-95.
25. Shoham S., Davenne D., Cady A.B., Dinarello C.A., Krueger J.M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol. 253:(1 Pt 2):1987;R142-R149.
26. Shimommura Y., Shimizu H., Takahashi M., Uehara Y., Negishi M., Sato N., et al. Effects of peripheral administration of recombinant human interleukin-1 beta on feeding behavior of the rat. Life Sci. 47:(24):1990;2185-2192.
27. Crestani F., Seguy F., Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res. 542:(2):1991;330-335.
28. Dunn A.J., Antoon M., Chapman Y. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin- releasing factor. Brain Res Bull. 26:(4):1991;539-542.
29. Krueger J.M., Kubillus S., Shoham S., Davenne D. Enhancement of slow-wave sleep by endotoxin and lipid A. Am J Physiol. 251:(3 Pt 2):1986;R591-R597.
30. Kluger M.J. Fever: role of pyrogens and cryogens. Physiol Rev. 71:(1):1991;93-127.
31. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 711:(1-2):1996;163-174.
32. Coelho A., Fioramonti J., Bueno L. Brain interleukin-1beta and tumor necrosis factor-alpha are involved in lipopolysaccharide-induced delayed rectal allodynia in awake rats. Brain Res Bull. 52:(3):2000;223-228.
33. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res. 27:(1):1994;157-162.
34. Buttini M., Boddeke H. Peripheral lipopolysaccharide stimulation induces interleukin-1 beta messenger RNA in rat brain microglial cells. Neuroscience. 65:(2):1995;523-530.
35. Gabellec M.M., Griffais R., Fillion G., Haour F. Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment. Brain Res Mol Brain Res. 31:(1-2):1995;122-130.
36. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., et al. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci. 18:(6):1998;2239-2246.
37. Quan N., Whiteside M., Herkenham M. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience. 83:(1):1998;281-293.
38. Turrin N.P., Gayle D., Ilyin S.E., Flynn M.C., Langhans W., Schwartz G.J., et al. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull. 54:(4):2001;443-453.
39. Lipton J.M., Macaluso A., Hiltz M.E., Catania A. Central administration of the peptide alpha-MSH inhibits inflammation in the skin. Peptides. 12:(4):1991;795-798.
40. Oka T., Oka K., Hosoi M., Hori T. Inhibition of peripheral interleukin-1 beta-induced hyperalgesia by the intracerebroventricular administration of diclofenac and alpha-melanocyte-stimulating hormone. Brain Res. 736:(1-2):1996;237-242.
41. Bluthe R.M., Dantzer R., Kelley K.W. Central mediation of the effects of interleukin-1 on social exploration and body weight in mice. Psychoneuroendocrinology. 22:(1):1997;1-11.
42. Laye S., Gheusi G., Cremona S., Combe C., Kelley K., Dantzer R., et al. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol. 279:(1):2000;R93-R98.
43. Rothwell N.J. Central effects of TNF alpha on thermogenesis and fever in the rat. Biosci Rep. 8:(4):1988;345-352.
44. Dascombe M.J., Rothwell N.J., Sagay B.O., Stock M.J. Pyrogenic and thermogenic effects of interleukin 1 beta in the rat. Am J Physiol. 256:(1 Pt 1):1989;E7-E11.
45. Walter J.S., Meyers P., Krueger J.M. Microinjection of interleukin-1 into brain: separation of sleep and fever responses. Physiol Behav. 45:(1):1989;169-176.
46. Plata-Salaman C.R., Oomura Y., Kai Y. Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res. 448:(1):1988;106-114.
47. Oka T., Aou S., Hori T. Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats. Brain Res. 624:(1-2):1993;61- 68.
48. Bluthe R.M., Michaud B., Kelley K.W., Dantzer R. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. Neuroreport. 7:(9):1996;1485-1488.
49. Reeve A.J., Patel S., Fox A., Walker K., Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain. 4:(3):2000;247-257.
50. Kobori N., Clifton G.L., Dash P. Altered expression of novel genes in the cerebral cortex following experimental brain injury. Brain Res Mol Brain Res. 104:(2):2002;148-158.
51. Agnello D., Wang H., Yang H., Tracey K.J., Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine. 18:(4):2002;231-236.
52. Johns E.W. Primary structures. Johns E.W. The HMG chromosomal proteins. 1982;85-86 Academic Press Inc. London.
53. Newton R., Kuitert L.M., Bergmann M., Adcock I.M., Barnes P.J. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun. 237:(1):1997;28-32.
54. Fiebich B.L., Mueksch B., Boehringer M., Hull M. Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. J Neurochem. 75:(5):2000;2020-2028.
55. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem. 270:(43):1995;25752- 25761.
56. Sousa M.M., Yan S.D., Stern D., Saraiva M.J. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Invest. 80:(7):2000;1101-1110.
57. Taguchi A., Blood D.C., del Toro G., Canet A., Lee D.C., Qu W., et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature. 405:(6784):2000;354-360.
58. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 101:(7):2003;2652-2660.
59. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol. 284:(4):2003;C870-C879.
60. Kimura K., Katoh N., Sakurada K., Kubo S. Phosphorylation of high mobility group 1 protein by phospholipid-sensitive Ca2+-dependent protein kinase from pig testis. Biochem J. 227:(1):1985;271-276.
61. Tanuma S., Yagi T., Johnson G.S. Endogenous ADP ribosylation of high mobility group proteins 1 and 2 and histone H1 following DNA damage in intact cells. Arch Biochem Biophys. 237:(1):1985;38-42.
62. Boffa L.C., Walker J., Chen T.A., Sterner R., Mariani M.R., Allfrey V.G. Factors affecting nucleosome structure in transcriptionally active chromatin. Histone acetylation, nascent RNA and inhibitors of RNA synthesis. Eur J Biochem. 194:(3):1990;811-823.
63. Dimov S.I., Alexandrova E.A., Beltchev B.G. Differences between some properties of acetylated and nonacetylated forms of HMG1 protein. Biochem Biophys Res Commun. 166:(2):1990;819-826.
64. Chao Y.B., Scovell W.M., Yan S.B. High mobility group protein, HMG-1, contains insignificant glycosyl modification. Protein Sci. 3:(12):1994;2452- 2454.
65. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3:(10):2002;995-1001.
66. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:(6894):2002;191-195.
67. Rendon-Mitchell B., Ochani M., Li J., Han J., Wang H., Yang H., et al. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol. 170:(7):2003;3890-3897.
68. Pugh C.R., Johnson J.D., Martin D., Rudy J.W., Maier S.F., Watkins L.R. Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments. Brain Res. 861:(1):2000;8-15.
69. Watkins L.R., Wiertelak E.P., Maier S.F. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels. Brain Res. 582:(1):1992;10-21.
70. Hansen M.K., O'Connor K.A., Goehler L.E., Watkins L.R., Maier S.F. The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol. 280:(4):2001;R929-R934.
71. Milligan E.D., Hinde J.L., Mehmert K.K., Maier S.F., Watkins L.R. A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats. J Neurosci Methods. 90:(1):1999;81-86.
72. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:(1):1994;55-63.
73. Milligan E.D., Mehmert K.K., Hinde J.L., Harvey L.O., Martin D., Tracey K.J., et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 861:(1):2000;105-116.
74. Harvey L.O. Efficient estimation of sensory thresholds. Behav Res Methods Instrum Comput. 18:1986;623-632.
75. Treutwein B., Strasburger H. Fitting the psychometric function. Percept Psychophys. 61:1999;87-106.
76. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.